9.57

0.42% +0.04

Boundless Bio Inc (BOLD)

Overview News Price History Discussions Forecast

Boundless Bio Inc stock is currently priced at $9.57, with a 24-hour trading volume of 7,907. It has seen a +0.42% increased in the last 24 hours and a -9.38% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $9.56 pivot point. If it approaches the $10.08 resistance level, significant changes may occur.

Previous Close:

$9.53

Open:

$9.14

24h Volume:

7,907

Market Cap:

$211.94M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+5.16%

1M Performance:

-9.38%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$8.945

$9.91

52W Range:

$8.51

$12.65

Boundless Bio Inc Stock (BOLD) Company Profile

Name

Boundless Bio Inc

Sector

Healthcare (1211)

Industry

Biotechnology (699)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BOLD's Discussions on Twitter

Boundless Bio Inc Stock (BOLD) Latest News

Wall Street Breakfast: The Week Ahead

Seeking Alpha

Boundless Bio Inc Stock (BOLD) Financials Data

There is no financial data for Boundless Bio Inc (BOLD). Check out other stocks for more information.

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.